| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/19/2009 | US20090075981 INHIBITORS OF p38 |
| 03/19/2009 | US20090075957 Xanthohumol compositions and methods of using same |
| 03/19/2009 | US20090075953 Deuterium-enriched ed-71 |
| 03/19/2009 | US20090075944 Deuterium-enriched ibandronate |
| 03/19/2009 | US20090075921 Bone/joint disease sensitivity gene and use thereof |
| 03/19/2009 | US20090075920 Deuterium-enriched decitabine |
| 03/19/2009 | US20090075908 Agent For Strengthening Calcium Containing Tissue and Use Thereof |
| 03/19/2009 | US20090075887 Treatment with Kallikrein Inhibitors |
| 03/19/2009 | US20090075877 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 03/19/2009 | US20090075872 Methods and means |
| 03/19/2009 | US20090074896 Extracts of Polygonum multiflorum Thunb, and preparation process and uses of the same |
| 03/19/2009 | US20090074889 Compositions and Methods for Treatment and Prevention of Osteoarthritis |
| 03/19/2009 | US20090074886 Gsk-3 inhibitors |
| 03/19/2009 | US20090074876 Peptide composition and a method of promoting cartilage formation |
| 03/19/2009 | US20090074871 Composition for filling bone defects |
| 03/19/2009 | US20090074859 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 03/19/2009 | US20090074844 Trenadermal absorption preparation |
| 03/19/2009 | US20090074842 Medicament patch |
| 03/19/2009 | US20090074841 Medicament-based patch |
| 03/19/2009 | US20090074837 Bioresorbable Calcium-Deficient Hydroxyapatite Hydrogel Composite |
| 03/19/2009 | US20090074833 Bridged polycyclic compound based compositions for controlling bone resorption |
| 03/19/2009 | US20090074763 Method for inhibiting bone resorption |
| 03/19/2009 | US20090074753 Platelet-derived growth factor compositions and methods of use thereof |
| 03/19/2009 | US20090074742 Protein, osteoclast differentiation inhibitor, inflammatory bone resorption therapeutic agent, gene, recombinant vector, method of manufacturing a protein, method of inhibiting osteoclast differentiation, and method of treating inflammatory bone resorption |
| 03/19/2009 | US20090074731 Method of isolation and use of cells derived from first trimester umbilical cord tissue |
| 03/19/2009 | US20090074728 Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase |
| 03/19/2009 | DE112005003001B4 Aus humanem Fettgewebe abgeleitete multipotente Stammzellen und diese enthaltende Zelltherapeutika Derived from human adipose tissue stem cells and multipotent stem cell therapeutics containing them |
| 03/19/2009 | CA2686439A1 Compound and device for treating bone and/or cartilage defects |
| 03/18/2009 | EP2036921A1 Use of Slit, nephrin, ephrin or semaphorin for treatment of cartilage diseases |
| 03/18/2009 | EP2036916A1 Composition for promoting the production of equol |
| 03/18/2009 | EP2036905A1 Pyridylisoxazole derivative |
| 03/18/2009 | EP2036895A1 Hsp90 inhibitor |
| 03/18/2009 | EP2036891A2 Isoquinoline inhibitors of P38 |
| 03/18/2009 | EP2036887A1 Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
| 03/18/2009 | EP2036561A1 Agent for overcoming resistance to anti-cancer agent |
| 03/18/2009 | EP2036560A1 (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione for the treatment of benign prostatic hypertrophy |
| 03/18/2009 | EP2036548A1 Prevention and treatment of inflammation-induced and/or immune-mediated bone loss |
| 03/18/2009 | EP2035429A1 FUSED [d]PYRIDAZIN-7-ONES |
| 03/18/2009 | EP2035386A1 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 03/18/2009 | EP2035030A2 Use of a soluble morphogenic protein complex for treating cartilage defects |
| 03/18/2009 | EP2035028A2 Methods for treating autoimmune diseases using a taci-ig fusion molecule |
| 03/18/2009 | EP2035019A1 Prevention and treatment of osteochondrosis in animals and humans |
| 03/18/2009 | EP2034987A1 New use for cannabinoid |
| 03/18/2009 | EP1677627B1 Dietetic preparation with hyaluronate for treatment of osteoporosis |
| 03/18/2009 | EP1399482B1 Determination of bone-sialoprotein in bodily fluids for oncological problems |
| 03/18/2009 | EP1386912B1 Cyclic amidine derivative |
| 03/18/2009 | CN101389656A Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same |
| 03/18/2009 | CN101389623A New salts of an indole derivative and their use in medicine |
| 03/18/2009 | CN101389610A Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors |
| 03/18/2009 | CN101389342A Therapeutic agent for degenerative arthritis |
| 03/18/2009 | CN101386605A Febustat novel crystal and preparation method thereof |
| 03/18/2009 | CN101386604A Aromatic nitrile-base thiazole derivatives for inhibiting xanthine oxidase activity, preparation method and application |
| 03/18/2009 | CN101385852A Preparation method of bone collagen tablet |
| 03/18/2009 | CN101385851A Methods and compositions for healing and repair of articular cartilage |
| 03/18/2009 | CN101385836A Traditional Chinese medicine composition containing poria cocos for treating dermatomyositis and preparation thereof |
| 03/18/2009 | CN101385832A Ventilation meridian oral liquid |
| 03/18/2009 | CN101385820A Traditional Chinese medicine composition containing ephedra for treating dermatomyositis and preparation thereof |
| 03/18/2009 | CN101385812A Traditional Chinese medicine composition containing epimeddium for treating dermatomyositis and preparation thereof |
| 03/18/2009 | CN101385810A Traditional Chinese medicine composition containing chinemys reevesii for treating dermatomyositis and preparation thereof |
| 03/18/2009 | CN101385805A Traditional Chinese medicine composition containing cicada-shell for treating dermatomyositis and preparation method thereof |
| 03/18/2009 | CN101385801A Traditional Chinese medicine preparation for treating hyperosteogeny |
| 03/18/2009 | CN101385794A Guizhen medicine for treating burn |
| 03/18/2009 | CN101385766A Traditional Chinese medicine preparation for treating femoral head necrosis, periostitis, osteoporosis |
| 03/18/2009 | CN101385743A Medicine for treating and preventing arthrosis and preparation method thereof |
| 03/18/2009 | CN100469793C Anti-osteopontin antibody and use thereof |
| 03/18/2009 | CN100469790C Production of recombinant BMP-2 |
| 03/18/2009 | CN100469784C Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 03/18/2009 | CN100469778C Novel fused imidazole derivative |
| 03/18/2009 | CN100469767C Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 03/18/2009 | CN100469390C Use of bromelain in preparing medicament for increasing individual IL-8 content |
| 03/18/2009 | CN100469388C Chinese medicine for treating femoral head necrosis |
| 03/17/2009 | US7504537 osteoarthritis or rheumatoid arthritis |
| 03/17/2009 | US7504482 Recombinant soluble Fc receptors |
| 03/17/2009 | US7504436 Bioisosteres of actinonin |
| 03/17/2009 | US7504412 Melanin concentrating hormone receptor antagonists; such as n-(2-cyclopropyl-3-methylimidazo[1,2-a]-pyridin-6-yl)-4-(2-pyridyl)benzamide; central nervous system, cardiovascular and metabolic disorders; synthesis |
| 03/17/2009 | US7504394 Bazedoxifene ascorbate |
| 03/17/2009 | US7504232 Identifying immunomodulators for diagnosis and treatment of inflammatory, granulomatous, fibrosis, multiple sclerosis, bacterial or viral diseases |
| 03/17/2009 | CA2412594C Pyrazino[1',2':1,6]pyrido[3-4-5] indole derivatives |
| 03/17/2009 | CA2412161C Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 03/17/2009 | CA2330025C Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src |
| 03/17/2009 | CA2328234C Compounds that inhibit the binding of integrins to their receptors |
| 03/17/2009 | CA2316351C Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity |
| 03/12/2009 | WO2009032943A2 Methods and compositions for delivery of growth factor to fibrous connective tissue |
| 03/12/2009 | WO2009031879A1 Pharmaceutical composition combining betamethasone (steroidal anti-inflammatory agent) and methocarbamol (muscle relaxant) and use thereof in the treatment of musculoskeletal diseases |
| 03/12/2009 | WO2009031878A1 Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency |
| 03/12/2009 | WO2009031705A1 PHARMACEUTICAL COMPOSITION FOR INHIBITING ACCUMULATION OF AMYLOID-β PROTEIN |
| 03/12/2009 | WO2009031606A1 Therapeutic and prophylactic agents for arthritis |
| 03/12/2009 | WO2009030492A2 Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion |
| 03/12/2009 | WO2009030066A1 Polyethylene glycol modified interferon alpha 2b and preparation method and applicatioins thereof |
| 03/12/2009 | WO2009030065A1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION |
| 03/12/2009 | WO2009010478A8 Use of piperidine derivatives as agonists of chemokine receptor activity |
| 03/12/2009 | WO2008140703A3 Synthetic peptide materials for joint reconstruction, repair and cushioning |
| 03/12/2009 | US20090069535 Ligand (ACT-4-L) to a Receptor on the Surface of Activated CD4+ T-Cells |
| 03/12/2009 | US20090069381 Deuterium-enriched raloxifene |
| 03/12/2009 | US20090069380 Deuterium-enriched aroxifene |
| 03/12/2009 | US20090069376 Substituted N [N-(sulphonylphenyl)sulfonyl-prolyl]-phenylalanine derivatives are antagonists of the very late antigen-4 integrin; ulcerative colitis, Crohn's disease, asthma, multiple sclerosis, rheumatoid arthritis |
| 03/12/2009 | US20090069371 Isoquinoline compounds |
| 03/12/2009 | US20090069332 Novel pyridazine derivatives and medicines containing the same as effective ingredients |
| 03/12/2009 | US20090069325 Piperidine Derivatives Useful as Modulators of Chemokine Receptor Activity |
| 03/12/2009 | US20090069321 Cyanomethyl substituted n-acyl tryptamines |